Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 743

1.

Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical Trial.

Choudhry NK, Isaac T, Lauffenburger JC, Gopalakrishnan C, Lee M, Vachon A, Iliadis TL, Hollands W, Elman S, Kraft JM, Naseem S, Doheny S, Lee J, Barberio J, Patel L, Khan NF, Gagne JJ, Jackevicius CA, Fischer MA, Solomon DH, Sequist TD.

JAMA Intern Med. 2018 Aug 6. doi: 10.1001/jamainternmed.2018.3189. [Epub ahead of print]

PMID:
30083727
2.

Area-level Predictors of Medication Nonadherence among U.S. Medicaid Beneficiaries with Lupus: A Multilevel Study.

Feldman CH, Costenbader KH, Solomon DH, Subramanian SV, Kawachi I.

Arthritis Care Res (Hoboken). 2018 Jul 28. doi: 10.1002/acr.23721. [Epub ahead of print]

PMID:
30055088
3.

Use of rheumatology-specific patient navigators to understand and reduce barriers to medication adherence: Analysis of qualitative findings.

Wohlfahrt A, Campos A, Iversen MD, Gagne JJ, Massarotti E, Solomon DH, Feldman CH.

PLoS One. 2018 Jul 19;13(7):e0200886. doi: 10.1371/journal.pone.0200886. eCollection 2018.

4.

Barriers to treatment adjustment within a treat to target strategy in rheumatoid arthritis: a secondary analysis of the TRACTION trial.

Zak A, Corrigan C, Yu Z, Bitton A, Fraenkel L, Harrold L, Smolen JS, Solomon DH.

Rheumatology (Oxford). 2018 Jul 5. doi: 10.1093/rheumatology/key179. [Epub ahead of print]

PMID:
29982720
5.

Assessment of Cardiovascular Risk in Older Patients with Gout Initiating Febuxostat versus Allopurinol: A Population-Based Cohort Study.

Zhang M, Solomon DH, Desai RJ, Kang EH, Liu J, Neogi T, Kim SC.

Circulation. 2018 Jun 13. pii: CIRCULATIONAHA.118.033992. doi: 10.1161/CIRCULATIONAHA.118.033992. [Epub ahead of print]

PMID:
29899013
6.

Association between inflammation and systolic blood pressure in RA compared to patients without RA.

Yu Z, Kim SC, Vanni K, Huang J, Desai R, Murphy SN, Solomon DH, Liao KP.

Arthritis Res Ther. 2018 Jun 1;20(1):107. doi: 10.1186/s13075-018-1597-9.

7.

Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in gout.

Bursill D, Taylor WJ, Terkeltaub R, Kuwabara M, Merriman TR, Grainger R, Pineda C, Louthrenoo W, Edwards NL, Andrés M, Vargas-Santos AB, Roddy E, Pascart T, Lin CT, Perez-Ruiz F, Tedeschi SK, Kim SC, Harrold LR, McCarthy G, Kumar N, Chapman PT, Tausche AK, Vazquez-Mellado J, Gutierrez M, Pinheiro GDRC, Richette P, Pascual E, Fisher MC, Burgos-Vargas R, Robinson PC, Singh JA, Jansen TL, Saag KG, Slot O, Uhlig T, Solomon DH, Keenan RT, Scire CA, Biernat-Kaluza E, Dehlin M, Nuki G, Schlesinger N, Janssen M, Stamp LK, Sivera F, Reginato AM, Jacobsson L, Lioté F, Ea HK, Rosenthal A, Bardin T, Choi HK, Hershfield MS, Czegley C, Choi SJ, Dalbeth N.

Arthritis Care Res (Hoboken). 2018 May 25. doi: 10.1002/acr.23607. [Epub ahead of print]

PMID:
29799677
8.

Subsequent Cardiovascular Events Among Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis: Patterns of Disease-Modifying Antirheumatic Drug Treatment.

Sparks JA, Lesperance T, Accortt NA, Solomon DH.

Arthritis Care Res (Hoboken). 2018 May 25. doi: 10.1002/acr.23609. [Epub ahead of print]

PMID:
29799667
9.

The potential benefits of aspirin for primary cardiovascular prevention in rheumatoid arthritis: a secondary analysis of the PRECISION Trial.

Solomon DH, Libby P, Yeomans ND, Wang Q, Wolski KE, Nissen SE, Husni ME.

Rheumatology (Oxford). 2018 Aug 1;57(8):1364-1369. doi: 10.1093/rheumatology/key105.

PMID:
29688503
10.

Impact of Changes in Inflammation on Estimated Ten-Year Cardiovascular Risk in Rheumatoid Arthritis.

Yu Z, Yang N, Everett BM, Frits M, Iannaccone C, Coblyn J, Weinblatt M, Shadick N, Solomon DH, Liao KP.

Arthritis Rheumatol. 2018 Apr 20. doi: 10.1002/art.40532. [Epub ahead of print]

PMID:
29676517
11.

No difference in cardiovascular risk of tocilizumab versus abatacept for rheumatoid arthritis: A multi-database cohort study.

Kim SC, Solomon DH, Rogers JR, Gale S, Klearman M, Sarsour K, Schneeweiss S.

Semin Arthritis Rheum. 2018 Mar 22. pii: S0049-0172(17)30810-7. doi: 10.1016/j.semarthrit.2018.03.012. [Epub ahead of print]

PMID:
29673963
12.

Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen.

Reed GW, Abdallah MS, Shao M, Wolski K, Wisniewski L, Yeomans N, Lüscher TF, Borer JS, Graham DY, Husni ME, Solomon DH, Libby P, Menon V, Lincoff AM, Nissen SE.

J Am Coll Cardiol. 2018 Apr 24;71(16):1741-1751. doi: 10.1016/j.jacc.2018.02.036.

PMID:
29673465
13.

Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial.

Yeomans ND, Graham DY, Husni ME, Solomon DH, Stevens T, Vargo J, Wang Q, Wisniewski LM, Wolski KE, Borer JS, Libby P, Lincoff AM, Lüscher TF, Bao W, Walker C, Nissen SE; PRECISION investigators.

Aliment Pharmacol Ther. 2018 Jun;47(11):1453-1463. doi: 10.1111/apt.14610. Epub 2018 Apr 17.

PMID:
29667211
14.

Pseudogout among Patients Fulfilling a Billing Code Algorithm for Calcium Pyrophosphate Deposition Disease.

Tedeschi SK, Solomon DH, Liao KP.

Rheumatol Int. 2018 Jun;38(6):1083-1088. doi: 10.1007/s00296-018-4029-x. Epub 2018 Apr 17.

PMID:
29666904
15.

Identification of monosodium urate crystal deposits in patients with asymptomatic hyperuricemia using dual-energy CT.

Wang P, Smith SE, Garg R, Lu F, Wohlfahrt A, Campos A, Vanni K, Yu Z, Solomon DH, Kim SC.

RMD Open. 2018 Mar 9;4(1):e000593. doi: 10.1136/rmdopen-2017-000593. eCollection 2018.

16.

Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients With Gout.

Kim SC, Neogi T, Kang EH, Liu J, Desai RJ, Zhang M, Solomon DH.

J Am Coll Cardiol. 2018 Mar 6;71(9):994-1004. doi: 10.1016/j.jacc.2017.12.052.

PMID:
29496000
17.

An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout.

Desai RJ, Franklin JM, Spoendlin-Allen J, Solomon DH, Danaei G, Kim SC.

PLoS One. 2018 Feb 28;13(2):e0193622. doi: 10.1371/journal.pone.0193622. eCollection 2018.

18.

Dynamic patterns and predictors of hydroxychloroquine nonadherence among Medicaid beneficiaries with systemic lupus erythematosus.

Feldman CH, Collins J, Zhang Z, Subramanian SV, Solomon DH, Kawachi I, Costenbader KH.

Semin Arthritis Rheum. 2018 Jan 8. pii: S0049-0172(17)30376-1. doi: 10.1016/j.semarthrit.2018.01.002. [Epub ahead of print]

PMID:
29458974
19.

Assessment of coronary vascular function with cardiac PET in relation to serum uric acid.

Kim SC, Shah NR, Rogers JR, Bibbo CF, Di Carli MF, Solomon DH.

PLoS One. 2018 Feb 13;13(2):e0192788. doi: 10.1371/journal.pone.0192788. eCollection 2018.

20.

Rheumatoid arthritis.

Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, Kavanaugh A, McInnes IB, Solomon DH, Strand V, Yamamoto K.

Nat Rev Dis Primers. 2018 Feb 8;4:18001. doi: 10.1038/nrdp.2018.1. Review.

PMID:
29417936
21.

A Development and Feasibility Study of a Peer Support Telephone Program in Rheumatoid Arthritis.

Shadick NA, Zibit MJ, Iannaccone CK, Thrower R, Sowell NF, Weinblatt ME, Solomon DH, Cui J.

J Clin Rheumatol. 2018 Feb 1. doi: 10.1097/RHU.0000000000000661. [Epub ahead of print] No abstract available.

PMID:
29389689
22.

Medical Care Costs Associated with Rheumatoid Arthritis in the US: A Systematic Literature Review and Meta-analysis.

Hresko A, Lin J, Solomon DH.

Arthritis Care Res (Hoboken). 2018 Jan 5. doi: 10.1002/acr.23512. [Epub ahead of print]

PMID:
29316377
23.

Benefits and Sustainability of a Learning Collaborative for Implementation of Treat to Target in Rheumatoid Arthritis: Results of the TRACTION Trial Phase II.

Solomon DH, Lu B, Yu Z, Corrigan C, Harrold LR, Smolen JS, Fraenkel L, Katz JN, Losina E.

Arthritis Care Res (Hoboken). 2018 Jan 5. doi: 10.1002/acr.23508. [Epub ahead of print]

PMID:
29316341
24.

Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis: A Randomized Clinical Trial.

Solomon DH, Husni ME, Wolski KE, Wisniewski LM, Borer JS, Graham DY, Libby P, Lincoff AM, Lüscher TF, Menon V, Yeomans ND, Wang Q, Bao W, Berger MF, Nissen SE; PRECISION Trial Investigators.

Arthritis Rheumatol. 2018 Apr;70(4):537-546. doi: 10.1002/art.40400.

PMID:
29266879
25.

Effects of analgesics on bone mineral density: A longitudinal analysis of the prospective SWAN cohort with three-group matching weights.

Yoshida K, Yu Z, Greendale GA, Ruppert K, Lian Y, Tedeschi SK, Lin TC, Haneuse S, Glynn RJ, Hernández-Díaz S, Solomon DH.

Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):182-190. doi: 10.1002/pds.4362. Epub 2017 Dec 12.

PMID:
29230890
26.

Reply.

Gravallese EM, Kay J, Duryea J, Solomon DH.

Arthritis Rheumatol. 2018 Mar;70(3):476. doi: 10.1002/art.40387. Epub 2018 Feb 6. No abstract available.

PMID:
29193854
27.

Editorial: Tumor Necrosis Factor Antagonists: Killing Two Birds With One Biologic Stone.

Bathon JM, Giles JT, Solomon DH.

Arthritis Rheumatol. 2018 Mar;70(3):326-329. doi: 10.1002/art.40376. Epub 2018 Feb 13. No abstract available.

PMID:
29145701
28.

Comparative Risk of Cardiovascular Outcomes Between Topical and Oral Nonselective NSAIDs in Taiwanese Patients With Rheumatoid Arthritis.

Lin TC, Solomon DH, Tedeschi SK, Yoshida K, Kao Yang YH.

J Am Heart Assoc. 2017 Oct 27;6(11). pii: e006874. doi: 10.1161/JAHA.117.006874.

29.

The effect of insulin on bone mineral density among women with type 2 diabetes: a SWAN Pharmacoepidemiology study.

Ruppert K, Cauley J, Lian Y, Zgibor JC, Derby C, Solomon DH.

Osteoporos Int. 2018 Feb;29(2):347-354. doi: 10.1007/s00198-017-4276-9. Epub 2017 Oct 27.

30.

Outcomes of lupus and rheumatoid arthritis patients with primary dengue infection: A seven-year report from Brazil.

de Abreu MM, Maiorano AC, Tedeschi SK, Yoshida K, Lin TC, Solomon DH.

Semin Arthritis Rheum. 2018 Apr;47(5):749-755. doi: 10.1016/j.semarthrit.2017.09.001. Epub 2017 Sep 8.

PMID:
29061443
31.

Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial.

Ruschitzka F, Borer JS, Krum H, Flammer AJ, Yeomans ND, Libby P, Lüscher TF, Solomon DH, Husni ME, Graham DY, Davey DA, Wisniewski LM, Menon V, Fayyad R, Beckerman B, Iorga D, Lincoff AM, Nissen SE.

Eur Heart J. 2017 Nov 21;38(44):3282-3292. doi: 10.1093/eurheartj/ehx508.

PMID:
29020251
32.

Risk of Hepatitis B Virus Reactivation in Patients With Inflammatory Arthritis Receiving Disease-Modifying Antirheumatic Drugs: A Systematic Review and Meta-Analysis.

Lin TC, Yoshida K, Tedeschi SK, de Abreu MM, Hashemi N, Solomon DH.

Arthritis Care Res (Hoboken). 2018 May;70(5):724-731. doi: 10.1002/acr.23346. Epub 2018 Apr 12.

PMID:
28834412
33.

Implementation of Treat-to-Target for Rheumatoid Arthritis in the US: Analysis of Baseline Data From a Randomized Controlled Trial.

Yu Z, Lu B, Agosti J, Bitton A, Corrigan C, Fraenkel L, Harrold LR, Losina E, Katz JN, Solomon DH.

Arthritis Care Res (Hoboken). 2018 May;70(5):801-806. doi: 10.1002/acr.23343. Epub 2018 Apr 12.

PMID:
28834390
34.

Rationale and Design of the Brigham Cohort for psoriasis and psoriatic arthritis registry (COPPAR).

Schneeweiss M, Merola JF, Karlson EW, Solomon DH.

BMC Dermatol. 2017 Aug 16;17(1):11. doi: 10.1186/s12895-017-0063-8.

35.

Patterns of Systemic Treatment for Psoriatic Arthritis in the US: 2004-2015.

Lee MP, Lii J, Jin Y, Desai RJ, Solomon DH, Merola JF, Kim SC.

Arthritis Care Res (Hoboken). 2018 May;70(5):791-796. doi: 10.1002/acr.23337. Epub 2018 Mar 23.

PMID:
28804988
36.

The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: A Secondary Analysis of the PRECISION Trial.

Solomon DH, Husni ME, Libby PA, Yeomans ND, Lincoff AM, Lϋscher TF, Menon V, Brennan DM, Wisniewski LM, Nissen SE, Borer JS.

Am J Med. 2017 Dec;130(12):1415-1422.e4. doi: 10.1016/j.amjmed.2017.06.028. Epub 2017 Jul 26.

PMID:
28756267
37.

Temporal Trends in Use of Biologic DMARDs for Rheumatoid Arthritis in the United States: A Cohort Study of Publicly and Privately Insured Patients.

Desai RJ, Solomon DH, Jin Y, Liu J, Kim SC.

J Manag Care Spec Pharm. 2017 Aug;23(8):809-814. doi: 10.18553/jmcp.2017.23.8.809.

38.

Relationship Between Fish Consumption and Disease Activity in Rheumatoid Arthritis.

Tedeschi SK, Bathon JM, Giles JT, Lin TC, Yoshida K, Solomon DH.

Arthritis Care Res (Hoboken). 2018 Mar;70(3):327-332. doi: 10.1002/acr.23295. Epub 2018 Feb 6.

PMID:
28635117
39.

Drug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurement.

Solomon DH, Shadick NA, Weinblatt ME, Zak A, Frits M, Franklin JM.

Arthritis Res Ther. 2017 Jun 13;19(1):130. doi: 10.1186/s13075-017-1330-0.

40.

Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus.

Barbhaiya M, Feldman CH, Guan H, Gómez-Puerta JA, Fischer MA, Solomon DH, Everett B, Costenbader KH.

Arthritis Rheumatol. 2017 Sep;69(9):1823-1831. doi: 10.1002/art.40174. Epub 2017 Aug 13.

PMID:
28598016
41.

Can Patient Navigators Improve Adherence to Disease-Modifying Antirheumatic Drugs? Quantitative Findings From a Six-Month Single-Arm Pilot Intervention.

Feldman CH, Wohlfahrt A, Campos A, Gagne JJ, Iversen MD, Massarotti E, Solomon DH, Kawachi I.

Arthritis Care Res (Hoboken). 2017 Jun 2. doi: 10.1002/acr.23302. [Epub ahead of print]

42.

Effects of Teriparatide on Joint Erosions in Rheumatoid Arthritis: A Randomized Controlled Trial.

Solomon DH, Kay J, Duryea J, Lu B, Bolster MB, Yood RA, Han R, Ball S, Coleman C, Lo E, Wohlfahrt A, Sury M, Yin M, Yu Z, Zak A, Gravallese EM.

Arthritis Rheumatol. 2017 Sep;69(9):1741-1750. doi: 10.1002/art.40156. Epub 2017 Jul 14.

PMID:
28544807
43.

Implementation of Treat-to-Target in Rheumatoid Arthritis Through a Learning Collaborative: Results of a Randomized Controlled Trial.

Solomon DH, Losina E, Lu B, Zak A, Corrigan C, Lee SB, Agosti J, Bitton A, Harrold LR, Pincus T, Radner H, Yu Z, Smolen JS, Fraenkel L, Katz JN.

Arthritis Rheumatol. 2017 Jul;69(7):1374-1380. doi: 10.1002/art.40111. Epub 2017 May 31.

44.

Clinical patient registry recruitment and retention: a survey of patients in two chronic disease registries.

Solomon DH, Shadick NA, Weinblatt ME, Frits M, Iannaccone C, Zak A, Korzenik JR.

BMC Med Res Methodol. 2017 Apr 17;17(1):59. doi: 10.1186/s12874-017-0343-3.

45.

Assessment of Confounders in Comparative Effectiveness Studies From Secondary Databases.

Franklin JM, Schneeweiss S, Solomon DH.

Am J Epidemiol. 2017 Mar 15;185(6):474-478. doi: 10.1093/aje/kww136.

PMID:
28399570
46.

Practice Pattern of Hepatitis B Testing in Rheumatoid Arthritis Patients: A Cross-National Comparison Between the US and Taiwan.

Lin TC, Hashemi N, Kim SC, Yang YK, Yoshida K, Tedeschi S, Desai R, Solomon DH.

Arthritis Care Res (Hoboken). 2018 Jan;70(1):30-38. doi: 10.1002/acr.23241. Epub 2017 Dec 8.

PMID:
28320050
47.

Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study.

Sparks JA, Barbhaiya M, Karlson EW, Ritter SY, Raychaudhuri S, Corrigan CC, Lu F, Selhub J, Chasman DI, Paynter NP, Ridker PM, Solomon DH.

Semin Arthritis Rheum. 2017 Aug;47(1):133-142. doi: 10.1016/j.semarthrit.2017.02.003. Epub 2017 Feb 10.

48.

Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study.

Kim SC, Solomon DH, Rogers JR, Gale S, Klearman M, Sarsour K, Schneeweiss S.

Arthritis Rheumatol. 2017 Jun;69(6):1154-1164. doi: 10.1002/art.40084. Epub 2017 Apr 28.

49.

Effect of Race and Ethnicity on Antihypertensive Medication Utilization Among Women in the United States: Study of Women's Health Across the Nation (SWAN).

Jackson EA, Ruppert K, Derby CA, Lian Y, Neal-Perry G, Habel LA, Tepper PG, Harlow SD, Solomon DH.

J Am Heart Assoc. 2017 Feb 23;6(3). pii: e004758. doi: 10.1161/JAHA.116.004758.

50.

Diet and Rheumatoid Arthritis Symptoms: Survey Results From a Rheumatoid Arthritis Registry.

Tedeschi SK, Frits M, Cui J, Zhang ZZ, Mahmoud T, Iannaccone C, Lin TC, Yoshida K, Weinblatt ME, Shadick NA, Solomon DH.

Arthritis Care Res (Hoboken). 2017 Dec;69(12):1920-1925. doi: 10.1002/acr.23225.

PMID:
28217907

Supplemental Content

Loading ...
Support Center